Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(5)
About
Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK
|
BSE: 532296
|
ISIN: INE935A01035
|
Industry: Pharmaceuticals
Analyst Buy
|
Strong Performer, Getting Expensive
2218.8000
-0.40
(
-0.02
%)
NSE
Jul 15, 2025
13:30 PM
New 52W High in past week
Volume:
1.2M
High vol.+gain this week
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Glenmark Pharmaceuticals Ltd.
15 Aug 2022, 12:00AM
Analyst Buy
2218.80
-0.02%
High base and weak US sales hit performance
Buy:
Glenmark Pharmaceuticals Ltd.
by
ICICI Securities Limited
Target: 478
Recommendation
Target
ICICI Securities Limited
Glenmark Pharma’s (Glenmark) Q1FY23 performance missed our estimates.
Glenmark Pharmaceuti.. has an
average target
of 1601.25 from 5 brokers.
More from Glenmark Pharmaceuticals Ltd.
Recommended
Market trades higher, KPI Green bags an order from GUVNL for a 150 MW wind power plant
Trendlyne Marketwatch |
15 Jul 2025, 01:23PM
IPO spree continues with Anthem and two SME issues opening this week
|
14 Jul 2025, 04:42PM
Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals
|
29 Jun 2020